Zimmer Biomet announces partnership with OSSIS as exclusive Asia Pacific distributor for patient-specific 3D printed titanium hip replacement joints

Zimmer Biomet

PR90366

 

SINGAPORE, July 1, 2021 /PRNewswire=KYODO JBN/ --

 

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in

musculoskeletal healthcare, today announced a partnership with OSSIS to serve

as the exclusive Asia Pacific distributor for its patient-specific 3D printed

titanium hip replacement joints.

 

OSSIS, a New Zealand based company, specializes in complex hip replacements

including second-time hip replacement, and replacement involving bone tumours

and trauma.

 

"This partnership will allow Zimmer Biomet to provide our extensive network of

orthopaedic surgeons with the option of patient-specific implants which are

crafted with a combination of clinical and engineering expertise," said Sang

Yi, Zimmer Biomet Asia Pacific Group President. "This will further strengthen

Zimmer Biomet's extensive portfolio of revision hip solutions and complementary

technologies, with the ultimate goal of providing innovative solutions for

complex cases and improving the quality of life of patients."

 

"The partnership with Zimmer Biomet will enhance OSSIS' ability to support

surgeons and patients alike and create a network across the Asia Pacific region

of cutting-edge technology and expert capability," said OSSIS Managing

Director, Kelvin Hyland. "This is an exciting step for OSSIS. Zimmer Biomet

shares our ethos of innovative technology, patient-specific solutions and

proven results."

 

About Zimmer Biomet

 

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global

leader in musculoskeletal healthcare. We design, manufacture and market

orthopaedic reconstructive products; sports medicine, biologics, extremities

and trauma products; office-based technologies; spine, craniomaxillofacial and

thoracic products; dental implants; and related surgical products.

 

We collaborate with healthcare professionals around the globe to advance the

pace of innovation. Our products and solutions help treat patients suffering

from disorders of, or injuries to, bones, joints or supporting soft tissues.

Together with healthcare professionals, we help millions of people live better

lives.

 

We have operations in more than 25 countries around the world and sell products

in more than 100 countries. For more information, visit www.zimmerbiomet.com or

follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

 

SOURCE Zimmer Biomet

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中